Cargando…
Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019
Aim: Recent studies on coronavirus disease 2019 (COVID-19) have not offered sufficient clinical evidence to support whether IFN-α can decrease the mortality of patients with COVID-19. Method: In this retrospective study, 103 of 1555 hospitalized COVID-19 patients were treated with IFN-α, and the oth...
Autores principales: | Liu, Hanqing, Ruan, Zhouru, Yin, Ziwei, Wu, Dan, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931619/ http://dx.doi.org/10.2217/fvl-2020-0404 |
Ejemplares similares
-
Timing of Intubation and In-Hospital Mortality in Patients With Coronavirus Disease 2019
por: Hyman, Jaime B., et al.
Publicado: (2020) -
Risk Factors for Mortality in Hospitalized Coronavirus Disease 2019 Patients
por: Dietl, Beatriz, et al.
Publicado: (2020) -
Diabetic ketoacidosis and high mortality among patients with coronavirus disease 2019 in a Peruvian hospital
por: Lopez‐Huamanrayme, Eddy, et al.
Publicado: (2021) -
Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals
por: Yehia, Baligh R., et al.
Publicado: (2020) -
In-Hospital Mortality Among Hospitalized Coronavirus Disease 2019 Patients in the United States: How Did It Change in 2021?
por: Moon, Rena C, et al.
Publicado: (2022)